Company announcementCompany-reported
What was reported
BURLINGTON, Mass. and JERUSALEM, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced it has entered into a strategic equity financing agreement with APS Innovations LLC, the parent company of Advanced Psychiatric Management LLC, a management services organization servicing multiple mental health clinics in the greater Chicago area (collectively, “Hopemark Health” or “Hopemark”).U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 6-K · May 18, 2026 · Open the source ↗
What the evidence supports
BrainsWay, a foreign private issuer, furnished a press release to the SEC (Form 6-K) about a company announcement. It shows what the company chose to disclose on that date.
What remains unknown
Claims in the release are the company's own and have not been independently verified. Furnishing a document to the SEC does not mean the SEC reviewed or endorsed it.
Figures as stated
Numbers exactly as written in the source. We don’t annualise, convert or add them up.
| Figure | In context |
|---|---|
| $1.5 million | “Under the terms of the agreement, BrainsWay will invest $1.5 million initially, with potential for an additional $1.5 million via milestone-based investments, for a minority position in Hopemark in the form of a preferred, annually compounding security.” |
Source passages
Exact excerpts from the source, with links. Quotes are checked character for character against our stored copy.
Press release headlineBrainsWay Announces Minority-Stake Investment in Hopemark HealthU.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 6-K · May 18, 2026 · Open the source ↗
Press release lead paragraphBURLINGTON, Mass. and JERUSALEM, Israel, May 18, 2026 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced it has entered into a strategic equity financing agreement with APS Innovations LLC, the parent company of Advanced Psychiatric Management LLC, a management services organization servicing multiple mental health clinics in the greater Chicago area (collectively, “Hopemark Health” or “Hopemark”).U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 6-K · May 18, 2026 · Open the source ↗
Amount stated in press releaseUnder the terms of the agreement, BrainsWay will invest $1.5 million initially, with potential for an additional $1.5 million via milestone-based investments, for a minority position in Hopemark in the form of a preferred, annually compounding security.U.S. Securities and Exchange Commission (EDGAR) · Exhibit 99.1 to 6-K · May 18, 2026 · Open the source ↗
Revision history
- Revision 1 · Oct 28, 2026, 20:52 UTC
BrainsWay Announces Minority-Stake Investment in Hopemark Health
Spotted an error? Tell us. Corrections are published, never silent: see all corrections.